학술논문
Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Document Type
Article
Author
Ascierto, Paolo A; McArthur, Grant A; Dréno, Brigitte; Atkinson, Victoria; Liszkay, Gabrielle; Di Giacomo, Anna Maria; Mandalà, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Dutriaux, Caroline; Garbe, Claus; Yan, Yibing; Wongchenko, Matthew; Chang, Ilsung; Hsu, Jessie J; Koralek, Daniel O; Rooney, Isabelle; Ribas, Antoni; Larkin, James
Source
In The Lancet Oncology September 2016 17(9):1248-1260
Subject
Language
ISSN
1470-2045